Twin Tree Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 753 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 800 |
|
2024
Q4 | – | Sell |
-28,105
| Closed | -$3.24M | – | 763 |
|
2024
Q3 | $3.24M | Buy |
+28,105
| New | +$3.24M | 0.01% | 260 |
|
2024
Q2 | – | Sell |
-19,147
| Closed | -$2.64M | – | 719 |
|
2024
Q1 | $2.64M | Sell |
19,147
-17,764
| -48% | -$2.45M | 0.01% | 249 |
|
2023
Q4 | $4.86M | Buy |
36,911
+12,712
| +53% | +$1.67M | 0.01% | 252 |
|
2023
Q3 | $2.72M | Buy |
24,199
+19,022
| +367% | +$2.14M | 0.01% | 220 |
|
2023
Q2 | $488K | Buy |
+5,177
| New | +$488K | ﹤0.01% | 375 |
|
2022
Q4 | – | Sell |
-12,477
| Closed | -$1.33M | – | 625 |
|
2022
Q3 | $1.33M | Buy |
12,477
+7,812
| +167% | +$830K | ﹤0.01% | 284 |
|
2022
Q2 | $455K | Sell |
4,665
-7,182
| -61% | -$700K | ﹤0.01% | 467 |
|
2022
Q1 | $1.11M | Buy |
11,847
+9,053
| +324% | +$849K | ﹤0.01% | 443 |
|
2021
Q4 | $238K | Sell |
2,794
-11,800
| -81% | -$1.01M | ﹤0.01% | 485 |
|
2021
Q3 | $1.4M | Sell |
14,594
-8,883
| -38% | -$852K | ﹤0.01% | 370 |
|
2021
Q2 | $2.29M | Buy |
23,477
+17,310
| +281% | +$1.68M | 0.01% | 301 |
|
2021
Q1 | $600K | Buy |
6,167
+4,397
| +248% | +$428K | ﹤0.01% | 363 |
|
2020
Q4 | $170K | Sell |
1,770
-5,880
| -77% | -$565K | ﹤0.01% | 395 |
|
2020
Q3 | $736K | Buy |
7,650
+2,479
| +48% | +$239K | ﹤0.01% | 296 |
|
2020
Q2 | $631K | Buy |
5,171
+5,121
| +10,242% | +$625K | ﹤0.01% | 359 |
|
2020
Q1 | $4K | Sell |
50
-2,589
| -98% | -$207K | ﹤0.01% | 495 |
|
2019
Q4 | $284K | Buy |
2,639
+122
| +5% | +$13.1K | ﹤0.01% | 340 |
|
2019
Q3 | $227K | Buy |
+2,517
| New | +$227K | ﹤0.01% | 339 |
|
2019
Q2 | – | Sell |
-2,118
| Closed | -$187K | – | 790 |
|
2019
Q1 | $187K | Sell |
2,118
-1,219
| -37% | -$108K | ﹤0.01% | 401 |
|
2018
Q4 | $238K | Buy |
+3,337
| New | +$238K | ﹤0.01% | 341 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 600 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 610 |
|